Clinical Trial Update: Phase 1 meCS6 + LT(R192G) Vaccine Study [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the meCS6 and LT(R192G) vaccine for diarrhea has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• LT(R192G) Vaccine (LT(R192G) vaccine)
• meCS6

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Diarrhea | Phase 1 | Status: WITHDRAWN